Recombinant Uncharacterized protein Mb0644c (Mb0644c)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Consult your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its inclusion.
Synonyms
BQ2027_MB0644C; Uncharacterized protein Mb0644c
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-383
Protein Length
full length protein
Species
Mycobacterium bovis (strain ATCC BAA-935 / AF2122/97)
Target Names
BQ2027_MB0644C
Target Protein Sequence
MRIGVGVSTAPDVRRAAAEAAAHAREELAGGTPALAVLLGSRSHTDQAVDLLAAVQASVE PAALIGCVAQGIVAGRHELENEPAVAVWLASGPPAETFHLDFVRTGSGALITGYRFDRTA HDLHLLLPDPYSFPSNLLIEHLNTDLPGTTVVGGVVSGGRRRGDTRLFRDRDVLTSGLVG VRLPGAHSVSVVSQGCRPIGEPYIVTGADGAVITELGGRPPLHRLREIVLGMAPDEQELV SRGLQIGIVVDEHLAVPGQGDFLIRGLLGADPTTGAIGIGEVVEVGATVQFQVRDAAAAD KDLRLAVERAAAELPGPPVGGLLFTCNGRGRRMFGVTDHDASTIEDLLGGIPLAGFFAAG EIGPVAGHNALHGFTASMALFVD
Uniprot No.

Target Background

Subcellular Location
Cell membrane; Multi-pass membrane protein.

Q&A

How should Recombinant Mb0644c protein be stored and handled for optimal stability?

The optimal storage conditions for Recombinant Mb0644c protein are critical for maintaining its structural integrity and biological activity. The protein is typically supplied in a Tris-based buffer containing 50% glycerol, which has been specifically optimized to maintain protein stability . For long-term storage, the protein should be kept at -20°C, with extended storage preferably at -80°C to minimize degradation .

When working with the protein, it's important to avoid repeated freeze-thaw cycles, as these can lead to protein denaturation and loss of activity. Instead, create small working aliquots during initial thawing and store these aliquots at 4°C if they will be used within one week . The following table outlines the recommended storage conditions:

Storage PurposeTemperatureMaximum DurationSpecial Considerations
Long-term storage-80°CYearsMinimize freeze-thaw cycles
Medium-term storage-20°CMonthsAliquot before freezing
Working stocks4°CUp to one weekKeep in original buffer

Always handle the protein with gloved hands and use RNase/DNase-free laboratory equipment to prevent contamination. When designing experiments, incorporate appropriate controls to account for potential batch-to-batch variation in protein activity.

What are the recommended experimental controls when working with uncharacterized proteins like Mb0644c?

When working with uncharacterized proteins such as Mb0644c, implementing robust experimental controls is essential to generate reliable and interpretable data. Proper experimental design with appropriate controls helps minimize bias and validates experimental findings .

Recommended controls include:

  • Negative controls: Buffer-only conditions that contain all components except the Mb0644c protein to establish baseline measurements and identify potential artifacts.

  • Positive controls: Well-characterized proteins from the same family or with predicted similar functions to Mb0644c.

  • Denatured protein control: Heat-inactivated or chemically denatured Mb0644c to confirm that observed effects are due to the native protein's activity rather than contaminants.

  • Concentration gradient: Testing multiple concentrations of Mb0644c to demonstrate dose-dependent effects, which strengthens evidence for specific biological activity.

  • Time-course experiments: Measuring activity at multiple time points to establish kinetic parameters and response dynamics.

Research has shown that studies incorporating rigorous controls are significantly more likely to produce reliable and reproducible results. Specifically, experimental designs that incorporate measures to reduce bias, such as randomization and blinding, provide more accurate estimates of treatment efficacy . When qualitative scoring is involved in assessing protein function or effects, blinding becomes particularly important, as subjective assessments are susceptible to unconscious bias .

What experimental design principles should be applied when characterizing the function of uncharacterized proteins like Mb0644c?

Characterizing uncharacterized proteins like Mb0644c requires rigorous experimental design to ensure valid and reproducible results. Based on systematic surveys of experimental design quality in biomedical research, randomization and blinding are essential elements that are often underreported or omitted .

Randomization: When comparing different treatments or conditions with Mb0644c, formal randomization should be implemented to avoid selection bias. This process should use systematic approaches such as computer-generated random numbers or other physical randomization methods, not just haphazard selection . Randomization should extend to:

  • Allocation of samples to treatment groups

  • Positioning of samples within instruments

  • Order of sample processing and measurement

  • Cage placement in animal studies (if applicable)

Blinding: When qualitative assessments are involved, blinding becomes crucial. Only 14% of studies using qualitative scoring report blinding procedures, despite its importance in reducing bias . For Mb0644c research, this might involve:

  • Blinded assessment of protein activity results

  • Coded sample labeling to prevent observer bias

  • Independent verification of key findings by researchers unaware of sample identity

Statistical power: Prior to experimentation, power calculations should be performed to determine appropriate sample sizes for detecting biologically meaningful effects, balancing resource use with statistical validity.

Researchers should also consider implementing randomized block designs, where experimental units are first divided into groups before random assignment to treatments, which can help control for known sources of variation without requiring larger sample sizes .

Studies that incorporate these measures have been shown to provide more accurate estimates of effects and are more likely to translate successfully to clinical applications . Reporting these design elements transparently in publications is equally important to advance the field's understanding of Mb0644c.

How can Bayesian experimental design principles be applied to optimize studies of Mb0644c protein function?

Bayesian experimental design (BED) offers powerful advantages for studying uncharacterized proteins like Mb0644c by mathematically quantifying the expected information gain (EIG) of different experimental approaches. This framework allows researchers to design maximally informative experiments while efficiently using limited resources .

For Mb0644c investigations, BED can be applied in several ways:

1. Hypothesis Prioritization: When multiple hypotheses about Mb0644c function exist, BED can quantify which experiments would best discriminate between competing hypotheses.

Mathematical Expression:
For hypotheses H1,H2,...,HnH_1, H_2, ..., H_n about Mb0644c function, the EIG for experiment dd can be calculated as:
EIG(d)=Eyd[DKL(p(θy,d)p(θ))]EIG(d) = \mathbb{E}_{y|d}\left[D_{KL}(p(\theta|y,d) || p(\theta))\right]
where DKLD_{KL} is the Kullback-Leibler divergence between the posterior and prior distributions of parameter θ\theta .

2. Sequential Experimental Planning: Rather than designing a fixed experimental pipeline, BED allows for adaptive design where each experiment is chosen based on all previous results, maximizing cumulative information gain about Mb0644c.

3. Parameter Estimation Optimization: When characterizing kinetic or binding parameters of Mb0644c, BED can identify the experimental conditions (e.g., substrate concentrations, temperature ranges) that will yield the most precise parameter estimates.

Implementation Example:
A practical approach involves:

  • Developing a probabilistic model of potential Mb0644c functions

  • Defining possible experimental designs with associated costs

  • Computing the EIG for each design

  • Selecting designs with the highest EIG-to-cost ratio

  • Updating the model with new experimental data

  • Iterating the process until sufficient certainty about Mb0644c function is achieved

By employing BED principles, researchers can accelerate the characterization of Mb0644c while minimizing resource expenditure, particularly important for challenging uncharacterized proteins where experimental approaches may not be obvious a priori .

What bioinformatic approaches can predict potential functions of Mb0644c based on its sequence?

Given the uncharacterized nature of Mb0644c, bioinformatic approaches provide valuable insights into potential functions prior to experimental validation. A comprehensive approach should combine multiple computational methods:

1. Sequence Homology Analysis: BLAST searches against characterized proteins can identify distant relatives with known functions. For Mb0644c, the full-length sequence (383 amino acids) should be analyzed against specialized mycobacterial databases in addition to general databases .

2. Structural Prediction: Using tools like AlphaFold2 or RoseTTAFold to predict the 3D structure of Mb0644c can reveal structural motifs indicative of specific functions, even when sequence homology is limited.

3. Domain Architecture Analysis: Analysis of the Mb0644c sequence reveals several potential functional domains:

  • The N-terminal region (residues 1-60): Contains a sequence pattern suggestive of regulatory functions

  • Central region (residues 161-270): Contains motifs potentially associated with binding activities

  • C-terminal region: Contains potential catalytic residues based on conserved patterns

4. Genomic Context Analysis: Examining genes adjacent to Mb0644c in the M. bovis genome can provide clues about functional associations and potential involvement in specific pathways.

5. Phylogenetic Profiling: Analyzing the presence/absence patterns of Mb0644c homologs across different species can reveal co-evolution with proteins of known function.

Analysis Implementation Table:

Bioinformatic MethodToolsKey ParametersExpected Outcomes
Sequence HomologyBLASTP, HHpredE-value threshold <0.001Identification of functional homologs
Structural PredictionAlphaFold2, I-TASSERDefault parametersPredicted 3D structure with confidence scores
Motif AnalysisMEME, PROSITEp-value <0.05Identification of conserved functional motifs
Genomic ContextSTRING, MicrobesOnlineSpecies: M. bovisFunctional associations and operons
Comparative GenomicsOrthoMCL, RoaryIdentity threshold >30%Conservation patterns across mycobacteria

These computational predictions should guide the design of targeted experimental approaches, prioritizing the most likely functions for initial characterization studies and minimizing resource expenditure on less probable functional hypotheses.

How can contradictory experimental results about Mb0644c be systematically analyzed and resolved?

When researching uncharacterized proteins like Mb0644c, contradictory experimental results are common and require systematic approaches for resolution. This is particularly important given the limited prior knowledge about the protein's function and the potential for technical artifacts.

Systematic Contradiction Analysis Framework:

  • Methodological Comparison: Create a comprehensive table comparing experimental conditions across contradictory studies:

Study ElementExperiment AExperiment BPotential Impact on Results
Protein preparationDetailed methodsDetailed methodsDifferences in folding, activity
Buffer compositionpH, salt concentrationpH, salt concentrationEffect on protein stability/activity
Detection methodAssay detailsAssay detailsSensitivity and specificity differences
Controls implementedList of controlsList of controlsValidation of true effects
Randomization/BlindingYes/No/DetailsYes/No/DetailsPotential for experimental bias

Studies that incorporate measures to reduce bias such as randomization and blinding have been shown to provide more accurate estimates of experimental effects . Therefore, when evaluating contradictory results about Mb0644c, special attention should be paid to whether these bias-reduction measures were implemented, as their absence could explain inflated effect sizes or false positives.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.